Search
for

    Did you mean Autoimmune Thyroiditis?
    Glossary Autoimmune Thyroiditis

    condition where immune system attacks thyroid gland, causing hypothyroidism

    Autoimmune Thyroiditis, also known as Hashimoto's Thyroiditis, is a condition where the immune system mistakenly attacks the thyroid gland, leading to chronic inflammation and often resulting in hypothyroidism (underactive thyroid). This can cause symptoms such as fatigue, weight gain, and depression, and is diagnosed through blood tests that detect thyroid antibodies and measure thyroid hormone levels.

    Related Terms

    Research

    5 / 1000+ results

      research [Hypothyroid myopathy in a young adult].

      2 citations , September 1993 in “PubMed”
      In this case report, a young man with primary hypothyroidism caused by autoimmune atrophic thyroiditis showed full recovery and normalization of metabolism after levothyroxine treatment.
      Epidemiology of Vitiligo, Associated Autoimmune Diseases, and Audiological Abnormalities: Ankara Study of 80 Patients in Turkey

      research Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey

      88 citations , February 2010 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
      This study reported that vitiligo patients in Turkey had a high prevalence of associated autoimmune diseases and auditory problems, suggesting vitiligo may be part of a systemic autoimmune process.
      Thyroid Diseases and Skin Autoimmunity

      research Thyroid diseases and skin autoimmunity

      24 citations , June 2018 in “Reviews in endocrine and metabolic disorders”
      This review discusses the epidemiology, clinical manifestations, and pathogenesis of autoimmune skin diseases and their associations with thyroid diseases, reporting no new clinical results.

      research The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

      71 citations , May 2024 in “New England Journal of Medicine”
      This study investigated the impact of the JAK inhibitor ruxolitinib on APS-1 patients, reporting that treatment decreased excessive T-cell-derived interferon-γ, normalized inflammatory markers, and led to remission of several autoimmune symptoms without serious adverse effects.